Academic literature on the topic 'Vaccines'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Vaccines.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Vaccines"

1

Ricke, Darrell O. "Epilepsy adverse events post vaccination." Exploration of Neuroscience 3, no. 6 (2024): 508–19. http://dx.doi.org/10.37349/en.2024.00062.

Full text
Abstract:
Aim: Seizure and epilepsy adverse events (AEs) can occur following vaccination. For epilepsy AEs, they are generally expected to only occur at background population frequencies without associations with immunizations. The Vaccine AEs Reporting System (VAERS) collects a subset of AEs experienced by vaccinees, including multiple epilepsy related AEs. This study examines the possibility of immunization associated epilepsy AEs in VAERS occurring above background rates. Methods: Herein, VAERS is retrospectively examined for epilepsy and seizure AEs following immunizations (AEFIs). Reported AEFIs ar
APA, Harvard, Vancouver, ISO, and other styles
2

Okanlawon, A. A., S. A. Ameen, R. A. Kadir, et al. "In vitro assessment of the potency of some Newcastle disease vaccine brands in Ibadan, Nigeria." African Journal of Clinical and Experimental Microbiology 21, no. 4 (2020): 328–32. http://dx.doi.org/10.4314/ajcem.v21i4.9.

Full text
Abstract:
Background: Newcastle disease (ND) is a very common and economically important disease of poultry. There is no drug for treatment of the disease during an outbreak in poultry flocks, and prevention by vaccination is one of the recommended control measures. However, post vaccination outbreaks have been observed on many occasions in chicken flocks and one of the causes has been attributed to possible failure of vaccine to confer immunity. This study was designed to evaluate the potency of ND vaccines available in Ibadan, Nigeria.
 Methodology: Haemagglutination (HA) technique and elution ph
APA, Harvard, Vancouver, ISO, and other styles
3

Luxi, Nicoletta, Francesco Ciccimarra, Chiara Bellitto, et al. "Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study." Vaccines 12, no. 9 (2024): 1059. http://dx.doi.org/10.3390/vaccines12091059.

Full text
Abstract:
Background: Conventional vaccines rarely cause severe allergic reactions. However, the rapid development and approval of COVID-19 vaccines left limited initial data on their adverse reactions, particularly in individuals with a history of allergy. The aim of this study was to assess and compare the safety profile of different doses and brands of COVID-19 vaccines in subjects with a history of allergy vs. those without a history of allergy. Methods: From February 2021 to February 2023, a web-based prospective study gathered vaccinee-reported outcomes using electronic questionnaires across eleve
APA, Harvard, Vancouver, ISO, and other styles
4

Ricke, Darrell O. "Etiology model for many vaccination adverse reactions, including SARS-CoV-2 spike vaccines." AIMS Allergy and Immunology 6, no. 4 (2022): 200–215. http://dx.doi.org/10.3934/allergy.2022015.

Full text
Abstract:
<abstract><sec> <title>Objective</title> <p>Vaccinated individuals (vaccinees) experience no adverse events, mild adverse events, multiple adverse events, or serious adverse events post vaccination. Many of these vaccine adverse events occur with different vaccines with different occurrence frequencies. Many of these adverse events are generally considered as associated with immune responses to the active vaccine components (antigens) and/or to possibly one or more of the vaccine excipients. Most of these vaccine adverse events are self-limiting and resolve within
APA, Harvard, Vancouver, ISO, and other styles
5

Broderick, Michael P., Sandra Romero-Steiner, Gowrisankar Rajam, et al. "Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone." Clinical and Vaccine Immunology 23, no. 8 (2016): 672–80. http://dx.doi.org/10.1128/cvi.00267-16.

Full text
Abstract:
ABSTRACTImmunological responses to vaccination can differ depending on whether the vaccine is given alone or with other vaccines. This study was a retrospective evaluation of the immunogenicity of a tetravalent meningococcal conjugate vaccine for serogroups A, C, W, and Y (MenACWY) administered alone (n= 41) or concomitantly with other vaccines (n= 279) to U.S. military personnel (mean age, 21.6 years) entering the military between 2006 and 2008. Concomitant vaccines included tetanus/diphtheria (Td), inactivated polio vaccine (IPV), hepatitis vaccines, and various influenza vaccines, among oth
APA, Harvard, Vancouver, ISO, and other styles
6

Trombetta, Claudia Maria, Otfried Kistner, Emanuele Montomoli, Simonetta Viviani, and Serena Marchi. "Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines." Vaccines 10, no. 5 (2022): 714. http://dx.doi.org/10.3390/vaccines10050714.

Full text
Abstract:
Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups. To date, three types of influenza vaccines have been licensed: inactivated, live-attenuated, and recombinant haemagglutinin vaccines. Effectiveness studies allow an assessment of the positive effects of influenza vaccines in the field. The effectiveness of current influenza is suboptimal, being estimated as 40% to 60% when the vaccines strains are antigenically well-matched with the circulating vir
APA, Harvard, Vancouver, ISO, and other styles
7

Yagovkin, E. A., G. G. Onishchenko, A. Yu Popova, et al. "Condition and Prospects of Development of Vaccines for Specific Prevention of Enterovirus (Nonpolio) Infection." Epidemiology and Vaccine Prevention 15, no. 4 (2016): 74–82. http://dx.doi.org/10.31631/2073-3046-2016-15-4-74-82.

Full text
Abstract:
This review summarizes the material on the development of vaccines against (nonpolio) enterovirus infection in Russia and abroad. Described the developed vaccine types, their characteristics and the results of clinical and epidemiological trials, created in China inactivated vaccines. I’is considered the possibility of creating a mucosal vaccines and vaccinal prevention strategies.
APA, Harvard, Vancouver, ISO, and other styles
8

Cojocaru, Ina, Oxana Grosu, Lilia Rotaru, Galina Corcea, Stela Odobescu, and Ion Moldovanu. "Neurological complications post – COVID-19 vaccination." Bulletin of the Academy of Sciences of Moldova. Medical Sciences 80, no. 3 (2025): 54–61. https://doi.org/10.52692/1857-0011.2024.3-80.09.

Full text
Abstract:
Following vaccination of the population against Covid-19 infection, a multitude of neurological complications have been reported, from the most frequently encountered to the rarest. In our article we present a narrative analysis of two databases: PubMed and Google Scholar for all types of published studies (case reports, case series, cross-sectional study with a meta-analytic literature review, systematic review, meta-analysis, retrospective study, cohort study). Headache is one of the most publicized, early onset complications, it can be migraine type - 51.1% and tension type - 27.4%, most fr
APA, Harvard, Vancouver, ISO, and other styles
9

Le, Ting, Chao Sun, Jitao Chang, Guijie Zhang, and Xin Yin. "mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases." Viruses 14, no. 2 (2022): 401. http://dx.doi.org/10.3390/v14020401.

Full text
Abstract:
In the prevention and treatment of infectious diseases, mRNA vaccines hold great promise because of their low risk of insertional mutagenesis, high potency, accelerated development cycles, and potential for low-cost manufacture. In past years, several mRNA vaccines have entered clinical trials and have shown promise for offering solutions to combat emerging and re-emerging infectious diseases such as rabies, Zika, and influenza. Recently, the successful application of mRNA vaccines against COVID-19 has further validated the platform and opened the floodgates to mRNA vaccine’s potential in infe
APA, Harvard, Vancouver, ISO, and other styles
10

Cheng, Liqin, Yan Wang, and Juan Du. "Human Papillomavirus Vaccines: An Updated Review." Vaccines 8, no. 3 (2020): 391. http://dx.doi.org/10.3390/vaccines8030391.

Full text
Abstract:
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated information about current HPV vaccines, focusing on vaccine coverage and efficacy. In addition, pan-gender vaccination and current clinical trials are also discussed. Currently, more efforts should be put into increasing the vaccine’s coverage, especially in low- and middle-income countries. Provision of education on HPV and vaccination is one
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Vaccines"

1

Farfan, Arribas Diego Jose. "DNA Vaccines Against HIV-1: Augmenting Immunogenicity of gp120." Link to electronic thesis, 2002. http://www.wpi.edu/Pubs/ETD/Available/etd-0107102-160706/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Parker, Christopher S. "Effect of a codon optimized DNA prime on induction of anti-influenza protective antibodies." Worcester, Mass. : Worcester Polytechnic Institute, 2007. http://www.wpi.edu/Pubs/ETD/Available/etd-040907-100839/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Satti, Iman. "Immunogenicity of anti-leishmaniasis vaccines in man /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-779-7/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rainczuk, Adam 1976. "Evaluation of DNA vaccine targeting strategies and expression library immunisation against lethal erythrocytic stage Malaria." Monash University, Dept. of Biochemistry and Molecular Biology, 2003. http://arrow.monash.edu.au/hdl/1959.1/5685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Grubb, Kimberley L. "A genomic approach to the identification of novel malaria vaccine antigens /." Thesis, McGill University, 2005. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=98715.

Full text
Abstract:
As the number of drug-resistant malaria parasites continues to grow, pressure is increasing to find an effective, cross-protective, multi-valent malaria vaccine (32). Expression library immunisation is an un-biased screening technique that leads to the identification of novel, protective antigens that can be administered as components of a multivalent DNA vaccine (9, 50, 75, 86, 92). Here, a P. c. adami DS expression library has been evaluated as a malaria vaccine in mice, and several subpools of cross-protective plasmids have been identified. Upon vaccination with these plasmid subpools, mice
APA, Harvard, Vancouver, ISO, and other styles
6

Atcheson, Erwan. "Prospects for enhancing malaria vaccine efficacy by combining pre-erythrocytic antigens." Thesis, University of Oxford, 2017. http://ora.ox.ac.uk/objects/uuid:6506c003-7065-4d48-b049-f5e9136443d5.

Full text
Abstract:
Malaria causes almost half a million deaths each year. Existing interventions will almost certainly not be enough to tackle this enormous public health problem on their own. An effective vaccine is urgently needed. The leading malaria vaccine, RTS,S, confers suboptimal protective efficacy, and in addition targets only Plasmodium falciparum and not the other major species of human malaria, P. vivax. This thesis investigates the potential of combining pre-erythrocytic malaria vaccines as a means of enhancing protective efficacy. A novel mathematical model was developed which expresses probabilit
APA, Harvard, Vancouver, ISO, and other styles
7

Hutchings, Claire L. "Combination vaccines." Thesis, University of Oxford, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.437038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Singh, Gagandeep. "RNA Viral Prophylaxis: Problems and Potential Solutions." Diss., North Dakota State University, 2019. https://hdl.handle.net/10365/29458.

Full text
Abstract:
Over 80% of the newly emerging infectious diseases are caused by RNA viruses. Major global problems associated with the development of vaccines against the RNA virus are their high genetic and antigenic diversity. Hence, effective control of epidemics with newly emerging RNA viruses require improved vaccines which are either specific to the new strain or broadly effective even when new viral strains emerge. The main focus of this dissertation is to develop epidemic vaccines using these two approaches. Using a newly emerged swine enteric virus called porcine epidemic diarrhea virus (PEDV) as a
APA, Harvard, Vancouver, ISO, and other styles
9

Khan, Tila. "Tailored influenza virus vaccines for both the young and old: Vaccine Efficacy of Whole Inactivated Vaccines bearing Immunomodulatory Adjuvants or Multimeric peptides." Diss., Virginia Tech, 2012. http://hdl.handle.net/10919/77130.

Full text
Abstract:
Influenza epidemics and pandemics remain a significant burden to world health and economy. Low efficacy of current inactivated influenza vaccines in the elderly and immunocompromized and the inability to protect against antigenically drifted or shifted strains of influenza virus are the two major problems in influenza vaccine research. To overcome these hurdles, we have utilized an in vitro cell culture vaccine platform, which results in whole inactivated influenza vaccine (WIV) bearing bioactive membrane-anchored immunomodulatory proteins such as cytokines on the virion surface, collectively
APA, Harvard, Vancouver, ISO, and other styles
10

Dannetun, Eva. "Reasons for non-vaccination /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-739-1/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Vaccines"

1

1925-, Brown Fred, and Cold Spring Harbor Laboratory, eds. Vaccines 90: Modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor Laboratory Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gregoriadis, Gregory, Anthony C. Allison, and George Poste, eds. Vaccines. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gregoriadis, Gregory, Brenda McCormack, and Anthony C. Allison, eds. Vaccines. Springer US, 1995. http://dx.doi.org/10.1007/978-1-4613-0357-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Domachowske, Joseph, and Manika Suryadevara, eds. Vaccines. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-58414-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Perlmann, Peter, and Hans Wigzell, eds. Vaccines. Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59955-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Misch, Kelly, Cathleen Dalton, and William D. Martineau. Vaccines. Freedonia Group, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sylvia, Engdahl, ed. Vaccines. Greenhaven Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

1932-, Plotkin Stanley A., and Orenstein Walter A, eds. Vaccines. 3rd ed. W.B. Saunders Co., 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Goldstein, Natalie. Vaccines. Chelsea House, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Laboratory, Cold Spring Harbor. Vaccines. Cold Spring Harbor Laboratory, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Vaccines"

1

Wu, Chung-Yi, and Chi-Huey Wong. "Vaccines Vaccine." In Glycoscience: Biology and Medicine. Springer Japan, 2014. http://dx.doi.org/10.1007/978-4-431-54841-6_198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jain, Ananya, and Shilpa Sharma. "Nanotechnology in COVID-19 Vaccines." In Proceedings of the Conference BioSangam 2022: Emerging Trends in Biotechnology (BIOSANGAM 2022). Atlantis Press International BV, 2022. http://dx.doi.org/10.2991/978-94-6463-020-6_3.

Full text
Abstract:
AbstractNanotechnology has been proposed in vaccine development as carriers and adjuvants time and again but received limited recognition before the development of vaccines for the COVID-19 pandemic. Nanotechnology has played a pivotal role in the triumph of the vaccines for the current pandemic caused by the SARS-CoV-2 virus. The first vaccine got approved within a year of the earliest reported case of the novel coronavirus. Presently, more than 35 vaccines are approved in at least one country, 10 out of which are sanctioned for emergency use by the WHO. The key categories include peptide vac
APA, Harvard, Vancouver, ISO, and other styles
3

Smith, G. L. "Recombinant vaccinia virus vaccines." In Recent Developments in Prophylactic Immunization. Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-1067-6_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Spithill, Terry W., Hayley Toet, Vignesh Rathinasamy, et al. "Vaccines for Fasciola: new thinking for an old problem." In Fasciolosis, 2nd ed. CABI, 2021. http://dx.doi.org/10.1079/9781789246162.0012.

Full text
Abstract:
Abstract This book chapter discusses the progression of fascioliasis vaccine research, as well as commercial considerations in fascioliasis vaccines development and characteristics of commercial vaccines.
APA, Harvard, Vancouver, ISO, and other styles
5

Knight, Stella C. "Dendritic Cells in the Induction of Immunity." In Vaccines. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Oosterlaken, Tom A. M., Theo Harmsen, Cornelis A. Kraaijeveld, and Harm Snippe. "Efficient Anti-Idiotypic Immunization with Homologous, Virus Neutralizing Monoclonal Antibodies Conjugated with KLH and Combined with Quil A." In Vaccines. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bartoloni, A., M. G. Pizza, A. Covacci, D. Nucci, L. Nencioni, and R. Rappuoli. "Protein Conformation Affects the Efficacy of Pertussis Vaccines." In Vaccines. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Epstein, M. A. "Vaccination Against Epstein-Barr Virus." In Vaccines. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hsu, K.-H., M. Lubeck, S. Mizutani, et al. "Adenovirus Vectored Vaccines." In Vaccines. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Makela, P. Helena, Helena Kayhty, Aino K. Takala, Heikki Peltola, and Juhani Eskola. "Vaccines Against Bacterial Infections of Children." In Vaccines. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Vaccines"

1

Kumar, Vishnu, Vijay Srinivasan, and Soundar Kumara. "Towards Smart Vaccine Manufacturing: A Preliminary Study During COVID-19." In ASME 2021 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2021. http://dx.doi.org/10.1115/imece2021-70516.

Full text
Abstract:
Abstract Biopharmaceutical community is devising modern techniques to boost the development, production, and distribution of COVID-19 vaccines in large scale with tremendous speed. This has shifted the focus towards smart manufacturing of vaccines through vaccine platforms. Vaccine platforms have great potential to rapidly generate new vaccines and can overcome the challenges of the traditional vaccine manufacturing approach without compromising on safety and efficacy. This preliminary study compares the traditional and modern vaccine manufacturing techniques, reviews COVID-19 vaccine manufact
APA, Harvard, Vancouver, ISO, and other styles
2

Eremets, V. I., A. V. Mishchenko, and S. A. Grin. "Advances in biotechnology in the industrial production of immunobiological drugs." In БИОТЕХНОЛОГИЯ: НАУЧНЫЕ ИССЛЕДОВАНИЯ И СВЯЗЬ С ПРОИЗВОДСТВОМ. Всероссийский научно-исследовательский и технологический институт биологической промышленности, 2024. https://doi.org/10.47804/978-5-89904-038-2-2024-24-32.

Full text
Abstract:
The article is devoted to a review of the literature on the formation of biotechnology as a science. The most significant, in the opinion of the authors, discoveries that have made a significant contribution to the development of biotechnological processes are presented. The achievements of biotechnology in the field of animal and human vaccine prophylaxis were noted separately. The main types of vaccines are described in brief. Examples of the creation of classic whole-virion vaccines are given (using the example of FMD vaccines). The main critical points in the technological chain (strains,
APA, Harvard, Vancouver, ISO, and other styles
3

Vujčić, Isidora, and Katarina Maksimović. "Perception of COVID-19 vaccination among Serbian medical students." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24045v.

Full text
Abstract:
Background: Although COVID-19 vaccination played a significant role in reducing pandemic spread, it is a subject of debate that creates confusion due to contradictory information coming from the scientific community and the media. The aims of this study were to obtain information on medical students' attitudes toward COVID-19 vaccination and to determine the main barriers to its acceptance. Methods and Objectives: A cross-sectional study was performed at the Faculty of Medicine University of Belgrade during the 2022-2023 winter season. A total of 730 medical students completed the questionnair
APA, Harvard, Vancouver, ISO, and other styles
4

Tarabrin, R. E., and E. S. Pyatigorec. "BIOETHICAL ISSUES OF VACCINOMICS." In I International Congress “The Latest Achievements of Medicine, Healthcare, and Health-Saving Technologies”. Kemerovo State University, 2023. http://dx.doi.org/10.21603/-i-ic-130.

Full text
Abstract:
Vaccinomics, as one of the areas of personalized medicine, can increase the effectiveness of
 vaccines, including in epidemics. Nevertheless, it is accompanied by a cluster of bioethical issues.
 The article explores possible bioethical difficulties associated with the development of personalized
 vaccines: the matching of the research subject and the person receiving the vaccine; the problem of
 confidential genetic data; equitable distribution of medical resources.
APA, Harvard, Vancouver, ISO, and other styles
5

Zughaier, Susu. "High Vaccine Coverage is Crucial for Preventing the Spread of Infectious Diseases During Mass Gathering." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0138.

Full text
Abstract:
Background: Vaccines are the most cost-effective intervention in public health as they prevent the spread of highly contagious infectious diseases. Because of vaccine implementation and high coverage, Measles was eradicated in 2000, however the recent reappearance of measles in the United States, Europe and globally is alarming. The resurgence of Measles, Diphtheria and Mumps is due to a reduction in vaccine coverage and herd immunity. Vaccine hesitant parents, antivaxxers, and fake news on vaccines are driving the surge in those infectious diseases. The World Health Organization issued the Gl
APA, Harvard, Vancouver, ISO, and other styles
6

Ermakova, M. Yu, S. V. Ivanov, A. A. Shishova, and A. A. Sinyugina. "OBTAINING MONOCLONAL ANTIBODIES TO POLIOVIRUS STRAINS SABIN FOR THE DEVELOPMENT OF AN ELISA TEST SYSTEM." In XI МЕЖДУНАРОДНАЯ КОНФЕРЕНЦИЯ МОЛОДЫХ УЧЕНЫХ: БИОИНФОРМАТИКОВ, БИОТЕХНОЛОГОВ, БИОФИЗИКОВ, ВИРУСОЛОГОВ, МОЛЕКУЛЯРНЫХ БИОЛОГОВ И СПЕЦИАЛИСТОВ ФУНДАМЕНТАЛЬНОЙ МЕДИЦИНЫ. IPC NSU, 2024. https://doi.org/10.25205/978-5-4437-1691-6-182.

Full text
Abstract:
Poliomyelitis is an acute infectious disease caused by the poliovirus. Two types of vaccines are used to prevent poliomyelitis: oral (live) polio vaccine and inactivated polio vaccine [1]. To test the immunogenicity of vaccine preparations, there is a need to develop a highly specific ELISA test system that will allow for intratype differentiation of polioviruses.
APA, Harvard, Vancouver, ISO, and other styles
7

Zhou, Luoyi Zhou, Ashenafi Kiros Wubshet, Jiangrong Zhang, et al. "The mRNA Vaccine Expressing Single and Fused Structural Proteins of Porcine Reproductive and Respiratory Syndrome Induces Strong Cellular and Humoral Immune Responses in BalB/C Mice." In БИОТЕХНОЛОГИЯ: НАУЧНЫЕ ИССЛЕДОВАНИЯ И СВЯЗЬ С ПРОИЗВОДСТВОМ. Всероссийский научно-исследовательский и технологический институт биологической промышленности, 2024. https://doi.org/10.47804/978-5-89904-038-2-2024-83-89.

Full text
Abstract:
Porcine reproductive and respiratory syndrome (PRRS) is a viral disease that causes significant economic losses. The development of a new and effective vaccine is key to the spread of the virus within the farm. Several vaccinations against PRRSV have been carried out using both traditional and alternative vaccines. Unfortunately, there is currently no vaccine that can completely stop this disease. Thus, our study aimed to develop an mRNA vaccine using antigens based on individual or fused PRRSV structural proteins. In this study, the nucleotide sequence of immunogenic mRNA was determined takin
APA, Harvard, Vancouver, ISO, and other styles
8

Bularca, Maria Cristina, Claudiu Coman, Luiza Mesesan Schmitz, Doina Draguinea, and Radu Tudorica. "THE ROLE OF ONLINE MEDIA CHANNELS IN PORTRAYING THE EFFECTS OF THE COVID-19 VACCINE." In 9th SWS International Scientific Conferences on SOCIAL SCIENCES - ISCSS 2022. SGEM WORLD SCIENCE, 2022. http://dx.doi.org/10.35603/sws.iscss.2022/s10.100.

Full text
Abstract:
During the COVID -19 pandemic, among other institutions, mass media has played an essential role in disseminating information about the evolution of the pandemic, but also in shaping peoples� opinion about the COVID - 19 vaccine. The purpose of our paper was to identify the way online media channels portrayed the positive and negative effects of the COVID � 19 vaccines in order to raise awareness regarding the importance of analyzing the subject from several perspectives. We considered such an analysis to be both necessary and relevant, because often, exposure to mass � media can determine peo
APA, Harvard, Vancouver, ISO, and other styles
9

Kozlova, A. D., M. S. Krasnikova, A. N. Bogomazova, M. B. Brusova, and S. P. Yatsentyuk. "High Resolution Melting (HRM) assay for differentiation of Massachusetts Gl-1 strains of infectious bronchitis virus in vaccines." In БИОТЕХНОЛОГИЯ: НАУЧНЫЕ ИССЛЕДОВАНИЯ И СВЯЗЬ С ПРОИЗВОДСТВОМ. Всероссийский научно-исследовательский и технологический институт биологической промышленности, 2024. https://doi.org/10.47804/978-5-89904-038-2-2024-130-134.

Full text
Abstract:
Confirmation of the identity of the strains is an important stage of control vaccines. Strains of Massachusetts genotype are most widely used in vaccines against infectious bronchitis of chickens. The aim of this work was to evaluate the possibility of using the HRM method to differentiate strains of this genotype. Primers were developed that amplify a 121 bp region of the S1 gene. A study of the three most commonly used strains in vaccines, H-120, B-48 and M-4 showed that differences in the melting point of amplicons obtained as a result of RT-PCR with selected primers make it possible to rel
APA, Harvard, Vancouver, ISO, and other styles
10

Srivastava, Priya. "Determinants of Vaccine Hesitancy Among Parents and Caregivers." In 28th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2024. http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.137_2024.

Full text
Abstract:
•Vaccination efforts in the United States and globally are one of the largest contributors to pediatric preventative health •Routine immunizations in the U.S for children ≤ 10 years old cover 14 vaccine-preventable diseases. As a result, an estimated 732,000 deaths, 21 million hospitalizations, and 322 diagnosed cases of diseases have been prevented between 1993 and 2013. •Vaccines remain a point of contention with pediatricians and their patients' caregivers •Many parents maintain hesitancy to give vaccines; to a number of reasons. Perceived risk and fear of side effects from vaccines more th
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Vaccines"

1

Hobbs, Abbi, and Peter Border. COVID-19 vaccines and virus transmission. Parliamentary Office of Science and Technology, 2021. http://dx.doi.org/10.58248/rr64.

Full text
Abstract:
COVID-19 vaccines have been deployed in the UK since December 2020. This article examines the impact of COVID-19 vaccines on transmission of the virus. It also considers the potential implications of vaccine-induced protection for easing lockdown restrictions and debate about potential introduction of immunity certification or a vaccine passport scheme.
APA, Harvard, Vancouver, ISO, and other styles
2

Smeaton, John, and Lydia Harriss. Manufacturing COVID-19 vaccines. Parliamentary Office of Science and Technology, 2021. http://dx.doi.org/10.58248/rr57.

Full text
Abstract:
The rapid production of safe, effective and consistent vaccines is essential for supporting COVID-19 immunisation programmes in the UK and globally. However, manufacturing vaccines is challenging for various reasons that include the complex processes involved, the specialist knowledge and experience required, and the natural variability of the biological materials and systems used. Urgent demand is leading to manufacturers and governments taking on significant financial risks in order to speed up production. What is the UK Government doing to accelerate vaccine manufacture? How are vaccines ma
APA, Harvard, Vancouver, ISO, and other styles
3

Ennis, Francis A., and Walter E. Demkowicz. Human Immune Responses to Experimental Vaccinia Vaccines. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada299784.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schmidt-Sane, Megan, Samantha Vanderslott, Hana Rohan, and Luisa Enria. Key Considerations: Using Social and Behavioural Science to Inform the Use of Vaccines During Health Emergencies. Institute of Development Studies, 2025. https://doi.org/10.19088/sshap.2025.013.

Full text
Abstract:
This brief synthesises social and behavioural science (SBS) research on the use of vaccines during health emergencies in sub-Saharan Africa, including vaccines undergoing clinical trials (‘experimental vaccines’). There are outbreaks of mpox, Marburg virus disease and Ebola (Sudan virus disease) in the region, and multiple clinical trials of vaccines for these diseases are in progress. Findings from SBS research can contribute to strategies to build confidence in vaccines and, importantly, the design of clinical trials and vaccine roll-out. To improve effective vaccine roll-out, it is critical
APA, Harvard, Vancouver, ISO, and other styles
5

Vagnoni, Cristiana. COVID-19 vaccines November update: progress of clinical trials. Parliamentary Office of Science and Technology, 2020. http://dx.doi.org/10.58248/rr50.

Full text
Abstract:
Vaccines are the most powerful tool against infectious diseases, and there are over 200 COVID-19 vaccines in development. Which COVID-19 vaccines are closer to the finish line? Which ones have been approved already for use in humans? When will a vaccine be available in the UK?
APA, Harvard, Vancouver, ISO, and other styles
6

Byrn, Stephen, Nathaniel Milton, and Kari Clase. BIRS Course: RNA Vaccine Manufacture and Assessment of Regulatory Documents for RNA Vaccines. Purdue University, 2023. http://dx.doi.org/10.5703/1288284317657.

Full text
Abstract:
This paper is in three segments: (A) Segment on Vaccine Manufacture; (B) Segment on Ready to Use (RTU) Fluid Path for Compounded Sterile Preparations, mRNA Vaccines, and Phage Therapy, (C) Segment on Competency Framework for Addressing Regulatory Review These segments can be used separately or in combination. Additionally, they can be presented in any order. The time devoted to each segment depends on the depth of the course coverage. These segments are interrelated and describe how to make vaccines, how to manufacture vaccines with a point-of-care system built from ready-to-use parts; and how
APA, Harvard, Vancouver, ISO, and other styles
7

Vagnoni, Cristiana, and Sarah Barber. Regulatory approval of COVID-19 vaccines in the UK. Parliamentary Office of Science and Technology, 2020. http://dx.doi.org/10.58248/rr53.

Full text
Abstract:
With several potential vaccines approaching the end of clinical trials, a new focus is how they will be approved for general use. How does this process work? Who will receive the first COVID-19 vaccines when they become available in the UK? What are public attitudes towards a COVID-19 vaccine in the UK?
APA, Harvard, Vancouver, ISO, and other styles
8

Gidengil, Courtney, Matthew Bidwell Goetz, Margaret Maglione, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepccer244.

Full text
Abstract:
Objective. To conduct a systematic review of the literature on the safety of vaccines recommended for routine immunization in the United States, updating the 2014 Agency for Healthcare Research and Quality (AHRQ) report on the topic. Data sources. We searched MEDLINE®, Embase®, CINAHL®, Cochrane CENTRAL, Web of Science, and Scopus through November 9, 2020, building on the prior 2014 report; reviewed existing reviews, trial registries, and supplemental material submitted to AHRQ; and consulted with experts. Review methods. This report addressed three Key Questions (KQs) on the safety of vaccine
APA, Harvard, Vancouver, ISO, and other styles
9

Vagnoni, Cristiana. COVID-19 vaccines safety and blood clots. Parliamentary Office of Science and Technology, 2021. http://dx.doi.org/10.58248/rr67.

Full text
Abstract:
The safety of COVID-19 vaccines currently deployed in the UK is closely monitored. This monitoring has shown that the University of Oxford/AstraZeneca vaccine is associated with very rare blood clots. What is known about these very rare adverse events?
APA, Harvard, Vancouver, ISO, and other styles
10

Vanderslott, Samantha, and Hana Rohan. Key considerations: Introducing experimental vaccines during health emergencies. Institute of Development Studies, 2025. https://doi.org/10.19088/sshap.2025.024.

Full text
Abstract:
This brief provides an overview of the experimental stages of vaccine development during a disease outbreak and highlights key considerations at each stage from a social science perspective. This brief complements a recent SSHAP publication that synthesised social and behavioural science (SBS) evidence on vaccine trials in health emergencies. This brief outlines designs and approaches to introducing experimental vaccines during health emergencies. It then presents the SBS and risk communication and community engagement (RCCE) dimensions to consider with the introduction of experimental vaccine
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!